Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries

Robert D. Safian, Melissa A. May, Anne Lichtenberg, Theodore L. Schreiber, Gregory Pavlides, Thomas B. Meany, Cindy L. Grines, William W. O'Neill

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objectives.: The purpose of this study was to describe the results of transluminal extraction coronary atherectomy in native coronary arteries. Background.: Transluminal extraction coronary atherectomy was approved by the Food and Drug Administration for use in native coronary arteries and vein grafts. Methods.: Between December 1988 and July 1992, transluminal extraction coronary atherectomy was performed in 181 native coronary arteries in 175 patients. A detailed angiographic and clinical assessment was performed. Results.: Quantitative angiography (mean ± SD) revealed an increase in minimal lumen diameter from 1.0 ± 0.6 mm before to 1.3 ± 0.7 mm after atherectomy, to 2.1 ± 0.8 mm after final treatment (p < 0.001), corresponding to a diameter stenosis of 70 ± 16%, 61 ± 21% and 36 ± 21%, respectively (p < 0.001). Final procedural success (final diameter stenosis <50%, no major complications) was achieved in 84%. Adjunctive angioplasty was used after atherectomy in 152 lesions (84%) to further enlarge lumen dimensions (130 lesions, 72%), salvage technical failures (2 lesions, 1%) and reverse atherectomy-induced abrupt closures (20 lesions, 11%). Clinical complications included death (2.3%), Q wave myocardial infarction (3.4%) and emergency bypass surgery (2.8%). The strongest independent correlate of major clinical complications was development of abrupt closure immediately after atherectomy (p = 0.01). Clinical follow-up of 92% of eligible patients revealed clinical restenosis (repeat intervention, late bypass surgery, myocardial infarction or death) in 28.5%. Angiographic follow-up of 83% of eligible lesions revealed a restenosis rate (diameter stenosis >50%) of 61%. Conclusions.: Transluminal extraction coronary atherectomy is limited by a modest degree of lumen enlargement, frequent need for adjunctive angioplasty and a high restenosis rate. For complex lesions in native coronary arteries, transluminal extraction coronary atherectomy appears to offer no advantage over conventional balloon angioplasty.

Original languageEnglish (US)
Pages (from-to)848-854
Number of pages7
JournalJournal of the American College of Cardiology
Volume25
Issue number4
DOIs
StatePublished - Mar 15 1995

Fingerprint

Coronary Atherectomy
Coronary Vessels
Atherectomy
Balloon Angioplasty
United States Food and Drug Administration
Angioplasty
Angiography
Transplants

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries. / Safian, Robert D.; May, Melissa A.; Lichtenberg, Anne; Schreiber, Theodore L.; Pavlides, Gregory; Meany, Thomas B.; Grines, Cindy L.; O'Neill, William W.

In: Journal of the American College of Cardiology, Vol. 25, No. 4, 15.03.1995, p. 848-854.

Research output: Contribution to journalArticle

Safian, Robert D. ; May, Melissa A. ; Lichtenberg, Anne ; Schreiber, Theodore L. ; Pavlides, Gregory ; Meany, Thomas B. ; Grines, Cindy L. ; O'Neill, William W. / Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries. In: Journal of the American College of Cardiology. 1995 ; Vol. 25, No. 4. pp. 848-854.
@article{c5d639548fa74105b06929dccb9c0398,
title = "Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries",
abstract = "Objectives.: The purpose of this study was to describe the results of transluminal extraction coronary atherectomy in native coronary arteries. Background.: Transluminal extraction coronary atherectomy was approved by the Food and Drug Administration for use in native coronary arteries and vein grafts. Methods.: Between December 1988 and July 1992, transluminal extraction coronary atherectomy was performed in 181 native coronary arteries in 175 patients. A detailed angiographic and clinical assessment was performed. Results.: Quantitative angiography (mean ± SD) revealed an increase in minimal lumen diameter from 1.0 ± 0.6 mm before to 1.3 ± 0.7 mm after atherectomy, to 2.1 ± 0.8 mm after final treatment (p < 0.001), corresponding to a diameter stenosis of 70 ± 16{\%}, 61 ± 21{\%} and 36 ± 21{\%}, respectively (p < 0.001). Final procedural success (final diameter stenosis <50{\%}, no major complications) was achieved in 84{\%}. Adjunctive angioplasty was used after atherectomy in 152 lesions (84{\%}) to further enlarge lumen dimensions (130 lesions, 72{\%}), salvage technical failures (2 lesions, 1{\%}) and reverse atherectomy-induced abrupt closures (20 lesions, 11{\%}). Clinical complications included death (2.3{\%}), Q wave myocardial infarction (3.4{\%}) and emergency bypass surgery (2.8{\%}). The strongest independent correlate of major clinical complications was development of abrupt closure immediately after atherectomy (p = 0.01). Clinical follow-up of 92{\%} of eligible patients revealed clinical restenosis (repeat intervention, late bypass surgery, myocardial infarction or death) in 28.5{\%}. Angiographic follow-up of 83{\%} of eligible lesions revealed a restenosis rate (diameter stenosis >50{\%}) of 61{\%}. Conclusions.: Transluminal extraction coronary atherectomy is limited by a modest degree of lumen enlargement, frequent need for adjunctive angioplasty and a high restenosis rate. For complex lesions in native coronary arteries, transluminal extraction coronary atherectomy appears to offer no advantage over conventional balloon angioplasty.",
author = "Safian, {Robert D.} and May, {Melissa A.} and Anne Lichtenberg and Schreiber, {Theodore L.} and Gregory Pavlides and Meany, {Thomas B.} and Grines, {Cindy L.} and O'Neill, {William W.}",
year = "1995",
month = "3",
day = "15",
doi = "10.1016/0735-1097(94)00505-K",
language = "English (US)",
volume = "25",
pages = "848--854",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries

AU - Safian, Robert D.

AU - May, Melissa A.

AU - Lichtenberg, Anne

AU - Schreiber, Theodore L.

AU - Pavlides, Gregory

AU - Meany, Thomas B.

AU - Grines, Cindy L.

AU - O'Neill, William W.

PY - 1995/3/15

Y1 - 1995/3/15

N2 - Objectives.: The purpose of this study was to describe the results of transluminal extraction coronary atherectomy in native coronary arteries. Background.: Transluminal extraction coronary atherectomy was approved by the Food and Drug Administration for use in native coronary arteries and vein grafts. Methods.: Between December 1988 and July 1992, transluminal extraction coronary atherectomy was performed in 181 native coronary arteries in 175 patients. A detailed angiographic and clinical assessment was performed. Results.: Quantitative angiography (mean ± SD) revealed an increase in minimal lumen diameter from 1.0 ± 0.6 mm before to 1.3 ± 0.7 mm after atherectomy, to 2.1 ± 0.8 mm after final treatment (p < 0.001), corresponding to a diameter stenosis of 70 ± 16%, 61 ± 21% and 36 ± 21%, respectively (p < 0.001). Final procedural success (final diameter stenosis <50%, no major complications) was achieved in 84%. Adjunctive angioplasty was used after atherectomy in 152 lesions (84%) to further enlarge lumen dimensions (130 lesions, 72%), salvage technical failures (2 lesions, 1%) and reverse atherectomy-induced abrupt closures (20 lesions, 11%). Clinical complications included death (2.3%), Q wave myocardial infarction (3.4%) and emergency bypass surgery (2.8%). The strongest independent correlate of major clinical complications was development of abrupt closure immediately after atherectomy (p = 0.01). Clinical follow-up of 92% of eligible patients revealed clinical restenosis (repeat intervention, late bypass surgery, myocardial infarction or death) in 28.5%. Angiographic follow-up of 83% of eligible lesions revealed a restenosis rate (diameter stenosis >50%) of 61%. Conclusions.: Transluminal extraction coronary atherectomy is limited by a modest degree of lumen enlargement, frequent need for adjunctive angioplasty and a high restenosis rate. For complex lesions in native coronary arteries, transluminal extraction coronary atherectomy appears to offer no advantage over conventional balloon angioplasty.

AB - Objectives.: The purpose of this study was to describe the results of transluminal extraction coronary atherectomy in native coronary arteries. Background.: Transluminal extraction coronary atherectomy was approved by the Food and Drug Administration for use in native coronary arteries and vein grafts. Methods.: Between December 1988 and July 1992, transluminal extraction coronary atherectomy was performed in 181 native coronary arteries in 175 patients. A detailed angiographic and clinical assessment was performed. Results.: Quantitative angiography (mean ± SD) revealed an increase in minimal lumen diameter from 1.0 ± 0.6 mm before to 1.3 ± 0.7 mm after atherectomy, to 2.1 ± 0.8 mm after final treatment (p < 0.001), corresponding to a diameter stenosis of 70 ± 16%, 61 ± 21% and 36 ± 21%, respectively (p < 0.001). Final procedural success (final diameter stenosis <50%, no major complications) was achieved in 84%. Adjunctive angioplasty was used after atherectomy in 152 lesions (84%) to further enlarge lumen dimensions (130 lesions, 72%), salvage technical failures (2 lesions, 1%) and reverse atherectomy-induced abrupt closures (20 lesions, 11%). Clinical complications included death (2.3%), Q wave myocardial infarction (3.4%) and emergency bypass surgery (2.8%). The strongest independent correlate of major clinical complications was development of abrupt closure immediately after atherectomy (p = 0.01). Clinical follow-up of 92% of eligible patients revealed clinical restenosis (repeat intervention, late bypass surgery, myocardial infarction or death) in 28.5%. Angiographic follow-up of 83% of eligible lesions revealed a restenosis rate (diameter stenosis >50%) of 61%. Conclusions.: Transluminal extraction coronary atherectomy is limited by a modest degree of lumen enlargement, frequent need for adjunctive angioplasty and a high restenosis rate. For complex lesions in native coronary arteries, transluminal extraction coronary atherectomy appears to offer no advantage over conventional balloon angioplasty.

UR - http://www.scopus.com/inward/record.url?scp=0028920699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028920699&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(94)00505-K

DO - 10.1016/0735-1097(94)00505-K

M3 - Article

C2 - 7884087

AN - SCOPUS:0028920699

VL - 25

SP - 848

EP - 854

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 4

ER -